Lilly’s next-gen drug outperforms Ozempic in weight loss trialEli Lilly’s experimental next-generation drug retatrutide achieved a greater...

Recent data from Novo Nordisk and Eli Lilly suggests GLP-1s can noticeably slow down people's molecular aging clocks.

A pair of studies have found evidence that GLP-1 users are more likely to lose their hair and nails.

Novo says new Ozempic shows lower cardiovascular risk compared with Lilly’s MounjaroOn Tuesday, Novo Nordisk said that a real-world study fo...

New research shows that off-label use of GLP-1s has surged in recent years.

MANASSAS, Va., Sept. 12, 2026 /PRNewswire/ -- Meant Health, a digital health platform that connects patients with licensed clinicians for ev...

Two recent studies have suggested that GLP-1 drugs can reduce the occurrence or severity of certain infections.

Leslie Mann is offering fans an update on her husband Judd Apatow’s journey on the controversial weight loss drug Ozempic.“He’s on Ozempic,...

VFX supervisor Betsy Paterson explains the character’s slimmer look in season five and how she pulled off the finale’s massive destruction s...

Psyllium husk is the latest supplement to become a wellness obsession. But can this humble fibre really live up to the hype? Lydia Spencer-E...

Two obesity specialists told Newsweek that the key to protecting muscle comes down to two simple habits.

Alabama Barker isn’t taking any hate from body-shamers.Alabama, 20, the daughter of Travis Barker and Shanna Moakler, took to TikTok over t...

New research suggests that hair loss can be a real, if tiny, risk of starting a GLP-1 drug like Ozempic.

In the weeks around the 2026 annual meeting of the American Society of Clinical Oncology, my phone kept buzzing with alerts about GLP-1 drug...